Urolithin A

A food-derived metabolite, also supplied directly. Some gut bacteria turn compounds in pomegranate, walnuts and berries into Urolithin A. Direct oral UA skips that conversion step. Pomegranate extract contains precursors, so its labeled milligrams are not milligrams of UA. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults (Official context · Accessed 2026-09-30)

Mitophagy means recycling damaged mitochondria. Mitochondria help cells supply usable energy; mitophagy is their selective cleanup process. This explains the longevity-community interest, rather than establishing lifespan extension or a reliable pre-workout boost. First-in-human Urolithin A study (Official context · Accessed 2026-09-30)

Source context — Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults: Sponsor-affiliated trial; secondary and within-group improvements must not be represented as uniformly positive comparisons with placebo.

Source context — First-in-human Urolithin A study: Abstract supports four-week biomarker context, not numerical half-life tables. Nature full text unavailable during this assignment.

More work before the muscles tire. One regular resistance-training user described harder HIIT and increased workout capacity, alongside post-workout tiredness. They did not report clearer thinking or extra energy in ordinary life. Urolithin A: three-week Mitopure experience (Personal report · Accessed 2026-09-30)

Less weakness or mental fatigue in some accounts. A long-term user with several chronic conditions described a modest ability to do more. A separate Nootropics user reported better concentration and motivation, but also mild insomnia and next-morning depletion with sleep-disordered breathing. Mitopure: longer use and stopping (Community discussion · Accessed 2026-09-30) · Anyone has experience with Urolithin A / Mitopure? (Community discussion · Accessed 2026-09-30)

Waiting longer does not guarantee a response. CFS commenters described no obvious UA improvement after a couple of months or about six months. The preserved 4–8-week energy checkpoint comes from vendor/community messaging, not a deadline for success. Mitopure/urolithin-a (Community discussion · Accessed 2026-09-30)

Fatigue is not proof that mitochondrial cleanup is working. The 500 mg floxies author and 700 mg Biohackers author speculated that feeling worse signaled beneficial mitophagy. Their accounts cannot demonstrate that mechanism or justify persisting through an adverse response. Mitophagy: Urolithin A vs. NAD+ (Community discussion · Accessed 2026-09-30) · Why would Urolithin A be making me feel exceptionally tired? (Community discussion · Accessed 2026-09-30)

Source context — Urolithin A: three-week Mitopure experience: Uncontrolled training report; no amount stated. Do not infer the dose from the brand. Cost and product doubts are opinions.

Source context — Mitopure: longer use and stopping: Long-term reporter has multiple diagnoses. Stopping comparison uncontrolled; noticing a difference within a week is not blood clearance or a withdrawal syndrome.

Source context — Anyone has experience with Urolithin A / Mitopure?: Unverified generic; severe sleep-disordered breathing confounds next-day depletion. Short self-report cannot establish a typical stimulant-like effect; mechanism speculation unproven.

Source context — Mitopure/urolithin-a: Different authors; chronic illness and large stack obscure attribution. No verified product composition or individual UA amount.

Source context — Mitophagy: Urolithin A vs. NAD+: Illness-specific accounts, other supplements and speculative fission/fusion theory. Positive generic account includes a discount code, creating promotional ambiguity; no visible answer to later follow-up.

Source context — Why would Urolithin A be making me feel exceptionally tired?: Retail amount and repeated stops/starts self-reported; no assay. Patent/trademark arguments cannot authenticate a bottle. Correspondence and testing assertions are secondhand.

Oral: 500 mg once daily appears in individual reports. The floxies discussion includes fatigue after one 500 mg Mitopure dose and clearer energy in a separate 500 mg generic account that also included a discount code. A Supplements poster used 500 mg each morning for a week. These are contrasting reports, not a recommended amount. Mitophagy: Urolithin A vs. NAD+ (Community discussion · Accessed 2026-09-30) · Urolithin a? Dosage? (Personal report · Accessed 2026-09-30)

500–1,000 mg/day is the recurring chart band. The preserved community record borrows this band from human trial arms. It also records cost-driven 250–500 mg amounts and descriptions of only marginal extra benefit after doubling. Those summaries do not establish a minimum effective dose.

Daily total and serving size matter. The old format notes describe 500 mg in two softgels or gummies, or one powder stick; four softgels total 1,000 mg. Added ingredients and reformulations make capsule counts unreliable across products. Does it work, and what about other brands? (Community discussion · Accessed 2026-09-30)

Source context — Mitophagy: Urolithin A vs. NAD+: Illness-specific accounts, other supplements and speculative fission/fusion theory. Positive generic account includes a discount code, creating promotional ambiguity; no visible answer to later follow-up.

Source context — Urolithin a? Dosage?: One week, unverified product, subjective benefit and sleep complaint. Reply proposes powder splitting; this is not adopted as a preparation instruction.

Source context — Does it work, and what about other brands?: Testing summarized by commenters, not an independently inspected assay in this assignment. Creator links and brand advocacy may be promotional; no buying guidance retained.

Reports range from 30–50 minutes to months. One Nootropics commenter described that rapid onset after oral 500 mg morning doses. The workout account placed change near day 3; the long-term floxies user needed a few months. These concern different outcomes and health contexts. Anyone has experience with Urolithin A / Mitopure? (Community discussion · Accessed 2026-09-30) · Urolithin A: three-week Mitopure experience (Personal report · Accessed 2026-09-30) · Mitopure: longer use and stopping (Community discussion · Accessed 2026-09-30)

Waiting longer does not guarantee a response. CFS commenters described no obvious UA improvement after a couple of months or about six months. The preserved 4–8-week energy checkpoint comes from vendor/community messaging, not a deadline for success. Mitopure/urolithin-a (Community discussion · Accessed 2026-09-30)

One account says throughout the day; persistence is uncertain. The rapid-response commenter described day-long mental benefit without a crash, alongside insomnia. Another person noticed a difference within a week of stopping after long use. Neither establishes a typical single-dose duration or a lasting benefit after discontinuation. Anyone has experience with Urolithin A / Mitopure? (Community discussion · Accessed 2026-09-30) · Mitopure: longer use and stopping (Community discussion · Accessed 2026-09-30)

An evening crash is a separate adverse pattern. A Biohackers poster reported 700 mg each morning and marked sleepiness about four hours before their usual bedtime, recurring across four or five stops and restarts. That timing is relative to bedtime, not four hours after swallowing. Why would Urolithin A be making me feel exceptionally tired? (Community discussion · Accessed 2026-09-30)

No measured community half-life. A Phoenix Rising poster with severe dysautonomia described a blood-pressure drop after an unspecified small amount, resolving after roughly 24 hours. They guessed this reflected half-life. Symptom recovery without blood sampling is not a clearance measurement; study values remain separate below. Urolithin A effects particularly in MCAS and cci (Personal report · Accessed 2026-09-30)

Human pharmacokinetics are separate from felt duration. The prior Andreux record lists approximately 17–22 hours for UA/UA-glucuronide and 25–58 hours for UA-sulfate, with peaks around 6–8 hours and plasma elimination over 72–96 hours. These are distinct analytes after direct oral study material; full PK tables were not reopened successfully here. Andreux 2019: preserved pharmacokinetic record (Official context · Accessed 2026-09-30)

Source context — Anyone has experience with Urolithin A / Mitopure?: Unverified generic; severe sleep-disordered breathing confounds next-day depletion. Short self-report cannot establish a typical stimulant-like effect; mechanism speculation unproven.

Source context — Urolithin A: three-week Mitopure experience: Uncontrolled training report; no amount stated. Do not infer the dose from the brand. Cost and product doubts are opinions.

Source context — Mitopure: longer use and stopping: Long-term reporter has multiple diagnoses. Stopping comparison uncontrolled; noticing a difference within a week is not blood clearance or a withdrawal syndrome.

Source context — Mitopure/urolithin-a: Different authors; chronic illness and large stack obscure attribution. No verified product composition or individual UA amount.

Source context — Why would Urolithin A be making me feel exceptionally tired?: Retail amount and repeated stops/starts self-reported; no assay. Patent/trademark arguments cannot authenticate a bottle. Correspondence and testing assertions are secondhand.

Source context — Urolithin A effects particularly in MCAS and cci: Unmeasured small amount; severe dysautonomia and low baseline blood pressure. Symptom resolution is not pharmacokinetic sampling. Separate pomegranate-extract account is not direct UA.

Source context — Andreux 2019: preserved pharmacokinetic record: Earlier canonical record says full article reviewed 2026-09-07. Current article/PDF attempts did not expose the full text or PK table; numerical values remain explicitly attributed to that prior record, not newly verified measurements.

Continuous use and finite trials coexist. The workout poster bought a two-month supply but questioned continuing because of cost. The modest-benefit user described about 1.5 years of use. CFS nonresponders questioned restocking. These are personal decisions, not a validated on/off cycle. Urolithin A: three-week Mitopure experience (Personal report · Accessed 2026-09-30) · Mitopure: longer use and stopping (Community discussion · Accessed 2026-09-30) · Mitopure/urolithin-a (Community discussion · Accessed 2026-09-30)

Breaks, race-prep blocks and step-down amounts remain lore. Earlier discussion includes multi-week pauses after 3–4 months, training-camp use, and 1,000 mg followed by 500 mg maintenance. No shared evidence establishes the best break, washout or maintenance schedule.

Source context — Urolithin A: three-week Mitopure experience: Uncontrolled training report; no amount stated. Do not infer the dose from the brand. Cost and product doubts are opinions.

Source context — Mitopure: longer use and stopping: Long-term reporter has multiple diagnoses. Stopping comparison uncontrolled; noticing a difference within a week is not blood clearance or a withdrawal syndrome.

Source context — Mitopure/urolithin-a: Different authors; chronic illness and large stack obscure attribution. No verified product composition or individual UA amount.

Stacks make a clean comparison difficult. NMN or NR, spermidine, CoQ10, PQQ and creatine appear alongside UA; advanced logs add SS-31, MOTS-c, rapamycin, metformin, resveratrol or SLU-PP-332. These are overlapping longevity/training discussions, not demonstrated combinations or fixed ingredient ratios. Mitopure/urolithin-a (Community discussion · Accessed 2026-09-30)

NAD stack (most common): UA + NMN or NR — mitophagy lever + NAD-precursor lever; no large validated synergy RCT, but ubiquitous in longevity spreadsheets. [community]

Autophagy duo: UA + spermidine — complementary “cleanup” story (mitophagy vs broader autophagy); published combined human trials sparse; unknown interaction caution sometimes noted. [community]

Mito kitchen sink: UA + CoQ10 and/or PQQ — electron-transport / biogenesis talk alongside mitophagy; highly confounded multi-supp logs. [community]

Creatine co-use: Practical muscle stack (creatine for phosphagen/strength; UA for mito quality narrative) — different mechanisms, often combined in training-focused users. [community]

Peptide-adjacent mito: UA interest next to SS-31 (elamipretide-class) or MOTS-c in advanced stacks — different routes/evidence; confounded. [community]

Source context — Mitopure/urolithin-a: Different authors; chronic illness and large stack obscure attribution. No verified product composition or individual UA amount.

An evening crash is a separate adverse pattern. A Biohackers poster reported 700 mg each morning and marked sleepiness about four hours before their usual bedtime, recurring across four or five stops and restarts. That timing is relative to bedtime, not four hours after swallowing. Why would Urolithin A be making me feel exceptionally tired? (Community discussion · Accessed 2026-09-30)

Fatigue is not proof that mitochondrial cleanup is working. The 500 mg floxies author and 700 mg Biohackers author speculated that feeling worse signaled beneficial mitophagy. Their accounts cannot demonstrate that mechanism or justify persisting through an adverse response. Mitophagy: Urolithin A vs. NAD+ (Community discussion · Accessed 2026-09-30) · Why would Urolithin A be making me feel exceptionally tired? (Community discussion · Accessed 2026-09-30)

Sleep, muscle aches and stomach symptoms are reported. Opened accounts include insomnia, dry mouth and muscle pain prompting a stop. Older discussion also records nausea, loose stool, mucus and night heat at 1,500 mg twice daily—3,000 mg/day. Those high-dose anecdotes do not establish a safe ceiling. Urolithin a? Dosage? (Personal report · Accessed 2026-09-30) · Anyone has experience with Urolithin A / Mitopure? (Community discussion · Accessed 2026-09-30)

Testing claims and trademark claims are different. One saved thread circulates a claim that four of ten tested brands matched their labels, while a reply asks whether a listed product now contains only precursors. Another thread disputes trademark-based judgments. None authenticates a current bottle or proves why someone felt worse. Does it work, and what about other brands? (Community discussion · Accessed 2026-09-30) · Why would Urolithin A be making me feel exceptionally tired? (Community discussion · Accessed 2026-09-30)

Disease treatment and lifelong safety remain separate questions. Illness-community stories do not establish a treatment for CFS, fluoroquinolone injury or neurological disease. The manufacturer flags pregnancy, breastfeeding, children and medication use for professional review; short studies do not settle lifelong high-dose exposure. Mitophagy: Urolithin A vs. NAD+ (Community discussion · Accessed 2026-09-30) · Mitopure/urolithin-a (Community discussion · Accessed 2026-09-30) · Mitopure FAQ (Official context · Accessed 2026-09-30)

Source context — Why would Urolithin A be making me feel exceptionally tired?: Retail amount and repeated stops/starts self-reported; no assay. Patent/trademark arguments cannot authenticate a bottle. Correspondence and testing assertions are secondhand.

Source context — Mitophagy: Urolithin A vs. NAD+: Illness-specific accounts, other supplements and speculative fission/fusion theory. Positive generic account includes a discount code, creating promotional ambiguity; no visible answer to later follow-up.

Source context — Urolithin a? Dosage?: One week, unverified product, subjective benefit and sleep complaint. Reply proposes powder splitting; this is not adopted as a preparation instruction.

Source context — Anyone has experience with Urolithin A / Mitopure?: Unverified generic; severe sleep-disordered breathing confounds next-day depletion. Short self-report cannot establish a typical stimulant-like effect; mechanism speculation unproven.

Source context — Does it work, and what about other brands?: Testing summarized by commenters, not an independently inspected assay in this assignment. Creator links and brand advocacy may be promotional; no buying guidance retained.

Source context — Mitopure/urolithin-a: Different authors; chronic illness and large stack obscure attribution. No verified product composition or individual UA amount.

Source context — Mitopure FAQ: Commercial claims exceed what individual reports demonstrate. Brand-specific guidance cannot establish every generic formulation's exposure or safety.